• Support MPN
Logo Logo
  • Investigations
  • Analysis
  • Cartoons
  • Podcasts
  • Videos
  • Language
    • 中文
    • русский
    • Español
    • Français
    • اَلْعَرَبِيَّةُ
  • Support MPN
  • Watch | Gaza Fights Back
President Donald Trump speaks during an event about prescription drug prices with Health and Human Services Secretary Alex Azar in the Rose Garden of the White House in Washington, Friday, May 11, 2018. (AP Photo/Carolyn Kaster)
Big Pharma

Trump’s Promise to Cut Drug Prices Turns Into Another Ploy to Enrich Industry, Blame Foreigners

Big Pharma, Big Oil and Big Banks Meet the Definition of Terrorists

Common threads persist throughout definitions of terrorism: violence, injury or death, intimidation, intentionality, multiple targets and political motivation. Big pharma, big oil and big banks meet them all.

April 30th, 2018
Paul Buchheit
April 30th, 2018
By Paul Buchheit
Big Oil

Various definitions of terrorism have been proposed in recent years, by organizations such as the FBI, the State Department, Homeland Security, and the ACLU. Some common threads persist throughout the definitions: violence, injury or death, intimidation, intentionality, multiple targets, political motivation. All the criteria are met by

Read Full Article

Study: Docs Who Get Company Cash Prescribe More Brand-Name Meds

The more money doctors receive from drug and medical device companies, the more brand-name drugs they tend to prescribe, a new ProPublica analysis shows. Even a meal can make a difference.

March 17th, 2016
ProPublica
March 17th, 2016
By ProPublica
Prescription drugs line a cabinet in this March 25, 2011 photo. (Photo by Eric Hunsaker via Flikr)

Doctors have long disputed that the payments they receive from pharmaceutical companies have any relationship to how they prescribe drugs. There’s been little evidence to settle the matter — until now. A ProPublica analysis has found for the first time that doctors who receive payments from the medical industry do indeed tend to prescribe

Read Full Article

FDA Policy: Big Pharma Firms Pay To Play

‘Instead of protecting the public health, the FDA has been allowing the drug companies to pay for a seat at a small table where all the rules were written.’

October 8th, 2013
Jacob Chamberlain
October 8th, 2013
By Jacob Chamberlain

Major pharmaceutical companies are engaging in "pay to play" arrangements that allow them to shape public policy on painkiller testing rules and regulations, according to e-mails obtained by a public records request. The Washington Post reports: A scientific panel that shaped the federal government’s policy for testing the safety and

Read Full Article

  • Contact Us
  • Archives
  • About Us
  • Privacy Policy
© 2025 MintPress News